The market is a fickle beast. The figures in the original post (including the December quarter) should show strong quarter on quarter growth. Expansion is underway with the HealthNotes acquisition. New products and revenue streams are under review (GP Link) and big pharma keep signing up (Pfizer).
They listed just over a year ago and have hit all milestones along the way. There are some fairly healthy performance bonuses for MMG based on GP Link / Home Medicine Reviews revenue ($7M revenue in 2 years of HMR commencing).
http://www.asx.com.au/asxpdf/20150924/pdf/431kdm55g545nn.pdf
December quarter, page-13
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MDR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
30.0¢ |
Change
0.010(3.45%) |
Mkt cap ! $215.0M | |||
| Open | High | Low | Value | Volume |
| 29.0¢ | 30.0¢ | 27.5¢ | $254.8K | 889.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 39326 | 30.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 30.5¢ | 2917 | 1 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| MDR (ASX) Chart |
